News Quantified

XNCR – xencor, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.

Xencor Reports Fourth Quarter and Full Year 2025 Financial Results

Xencor to Participate at Upcoming Investor Conferences [Yahoo! Finance]

Xencor to Participate at Upcoming Investor Conferences

What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector [Yahoo! Finance]

13.1%

BEAT

-2.6%

BEAT

-2.3%

BEAT

10.1%

MISS

Form S-8 Xencor Inc

Form S-3ASR Xencor Inc

Form 10-K Xencor Inc For: Dec 31

Form 8-K Xencor Inc For: Feb 25

Form SCHEDULE 13G/A Xencor Inc Filed by: EcoR1 Capital, LLC

Top News Gainers

6/24 MarketAxess Holdings Set to Join S&P 500; Axon Enterprise to Join S&P MidCap 400; Others to Join S&P SmallCap 600 13.8%

5/9 Xencor Reports First Quarter 2019 Financial Results 10.3%

6/30 Xencor: Multiple Data Readouts In Second Half Of 2019 For This 'Picks And Shovels' Play [Seeking Alpha] 7.2%

2/5 Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development of Next-Generation Food Allergy Treatments 6.1%

3/4 Xencor Inc (NASDAQ: XNCR) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $28.00 price target on the stock. 5.7%

3/25 Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend™ XmAb® Antibody Technology in Investigational Antibodies to Treat COVID-19 5.3%

8/8 Xencor Inc (NASDAQ: XNCR) had its price target raised by analysts at Canaccord Genuity from $45.00 to $52.00. They now have a "buy" rating on the stock. 5.0%

3/23 Form 4 Xencor Inc For: Mar 19 Filed by: STAFFORD JOHN S III 4.7%

6/27 Xencor Announces the Planned Retirement of Chief Medical Officer Paul Foster, M.D. 3.6%

1/30 Xencor Inc (NASDAQ: XNCR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating on the stock. 3.2%

Top News Decliners

8/6 Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -20.0%

12/26 Form 4 Xencor Inc For: Dec 20 Filed by: STAFFORD JOHN S III -8.4%

5/12 Xencor Inc (NASDAQ: XNCR) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $40.00 price target on the stock. -7.5%

4/29 Form DEF 14A Xencor Inc For: Jun 25 -6.7%

8/21 Form 4 Xencor Inc For: Aug 19 Filed by: Desjarlais John R -6.1%

8/22 Form 4 Xencor Inc For: Aug 21 Filed by: Kuch John J -5.6%

1/8 Form 4 Xencor Inc For: Jan 06 Filed by: STAFFORD JOHN S III -5.0%

4/30 Xencor to Host First Quarter 2020 Financial Results Webcast and Conference Call on May 7, 2020 -4.0%

1/25 Xencor Inc (NASDAQ: XNCR) had its "buy" rating re-affirmed by analysts at Zacks Investment Research. They now have a $42.00 price target on the stock. -3.9%

2/26 Xencor Inc (NASDAQ: XNCR) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -3.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day